{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T03:02:34Z","timestamp":1769569354183,"version":"3.49.0"},"reference-count":67,"publisher":"Impact Journals, LLC","issue":"27","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2015,9,15]]},"DOI":"10.18632\/oncotarget.4346","type":"journal-article","created":{"date-parts":[[2015,9,16]],"date-time":"2015-09-16T17:47:25Z","timestamp":1442425645000},"page":"23480-23495","source":"Crossref","is-referenced-by-count":67,"title":["miR-193a-3p is a potential tumor suppressor in malignant pleural mesothelioma"],"prefix":"10.18632","volume":"6","author":[{"given":"Marissa","family":"Williams","sequence":"first","affiliation":[{"name":"Asbestos Diseases Research Institute (ADRI), Sydney, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michaela B.","family":"Kirschner","sequence":"additional","affiliation":[{"name":"Asbestos Diseases Research Institute (ADRI), Sydney, Australia"},{"name":"Sydney Medical School, The University of Sydney, Sydney, Australia"},{"name":"Division of Thoracic Surgery, University Hospital Zurich, Zurich, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuen Yee","family":"Cheng","sequence":"additional","affiliation":[{"name":"Asbestos Diseases Research Institute (ADRI), Sydney, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacky","family":"Hanh","sequence":"additional","affiliation":[{"name":"Asbestos Diseases Research Institute (ADRI), Sydney, Australia"},{"name":"Faculty of Pharmacy, The University of Sydney, Sydney, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jocelyn","family":"Weiss","sequence":"additional","affiliation":[{"name":"EnGeneIC Ltd., Lane Cove, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy","family":"Mugridge","sequence":"additional","affiliation":[{"name":"EnGeneIC Ltd., Lane Cove, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Casey M.","family":"Wright","sequence":"additional","affiliation":[{"name":"Asbestos Diseases Research Institute (ADRI), Sydney, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony","family":"Linton","sequence":"additional","affiliation":[{"name":"Asbestos Diseases Research Institute (ADRI), Sydney, Australia"},{"name":"Sydney Medical School, The University of Sydney, Sydney, Australia"},{"name":"Department of Medical Oncology, Concord Repatriation General Hospital, Sydney, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven C.","family":"Kao","sequence":"additional","affiliation":[{"name":"Asbestos Diseases Research Institute (ADRI), Sydney, Australia"},{"name":"Sydney Medical School, The University of Sydney, Sydney, Australia"},{"name":"Department of Medical Oncology, Chris O'Brien Lifehouse, Sydney, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. James B.","family":"Edelman","sequence":"additional","affiliation":[{"name":"Cardiothoracic Surgical Unit, Royal Prince Alfred Hospital, The Baird Institute and Faculty of Medicine, The University of Sydney, Sydney, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael P.","family":"Vallely","sequence":"additional","affiliation":[{"name":"Cardiothoracic Surgical Unit, Royal Prince Alfred Hospital, The Baird Institute and Faculty of Medicine, The University of Sydney, Sydney, Australia"},{"name":"Australian School of Advanced Medicine, Macquarie University, Sydney, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian C.","family":"McCaughan","sequence":"additional","affiliation":[{"name":"Sydney Cardiothoracic Surgeons, RPA Medical Centre, Sydney, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy","family":"Cooper","sequence":"additional","affiliation":[{"name":"Sydney Medical School, The University of Sydney, Sydney, Australia"},{"name":"Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonja","family":"Klebe","sequence":"additional","affiliation":[{"name":"Department of Anatomical Pathology, Flinders Medical Centre, Adelaide, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruby C.Y.","family":"Lin","sequence":"additional","affiliation":[{"name":"Asbestos Diseases Research Institute (ADRI), Sydney, Australia"},{"name":"School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Himanshu","family":"Brahmbhatt","sequence":"additional","affiliation":[{"name":"EnGeneIC Ltd., Lane Cove, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"MacDiarmid","sequence":"additional","affiliation":[{"name":"EnGeneIC Ltd., Lane Cove, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nico","family":"van Zandwijk","sequence":"additional","affiliation":[{"name":"Asbestos Diseases Research Institute (ADRI), Sydney, Australia"},{"name":"Sydney Medical School, The University of Sydney, Sydney, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glen","family":"Reid","sequence":"additional","affiliation":[{"name":"Asbestos Diseases Research Institute (ADRI), Sydney, Australia"},{"name":"Sydney Medical School, The University of Sydney, Sydney, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2015,6,22]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.1158\/0008-5472.CAN-05-3907","article-title":"Global gene expression profiling of pleural mesotheliomas: overexpression of aurora kinases and P16\/CDKN2A deletion as prognostic factors and critical evaluation of microarray-based prognostic prediction","volume":"66","author":"Ladanyi","year":"2006","journal-title":"Cancer Res"},{"key":"2","doi-asserted-by":"crossref","first-page":"e6554","DOI":"10.1371\/journal.pone.0006554","article-title":"Genome-wide profile of pleural mesothelioma versus parietal and visceral pleura: the emerging gene portrait of the mesothelioma phenotype","volume":"4","author":"Larsson","year":"2009","journal-title":"PloS one"},{"key":"3","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.lungcan.2009.03.016","article-title":"Malignant pleural mesothelioma: genome-wide expression patterns reflecting general resistance mechanisms and a proposal of novel targets","volume":"67","author":"Lundgren","year":"2010","journal-title":"Lung cancer"},{"key":"4","first-page":"3080","article-title":"Gene expression profiling of malignant mesothelioma","volume":"9","author":"Albelda","year":"2003","journal-title":"Clinical cancer research : an official journal of the American Association for Cancer Research"},{"key":"5","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1097\/JTO.0b013e31820db125","article-title":"MicroRNAs Dysregulation in Human Malignant Pleural Mesothelioma","volume":"6","author":"Tognon","year":"2011","journal-title":"J Thorac Oncol"},{"key":"6","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/gcc.20669","article-title":"CDKN2A, NF2, and JUN are dysregulated among other genes by miRNAs in malignant mesothelioma -A miRNA microarray analysis","volume":"48","author":"Knuutila","year":"2009","journal-title":"Genes Chromosomes Cancer"},{"key":"7","doi-asserted-by":"crossref","first-page":"22809","DOI":"10.1074\/jbc.M110.100354","article-title":"Pro-tumorigenic effects of miR-31 loss in mesothelioma","volume":"285","author":"Pass","year":"2010","journal-title":"J Biol Chem"},{"key":"8","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.1093\/annonc\/mdt412","article-title":"Restoring expression of miR-16: a novel approach to therapy for malignant pleural mesothelioma","volume":"24","author":"van Zandwijk","year":"2013","journal-title":"Annals of oncology : official journal of the European Society for Medical Oncology \/ ESMO"},{"key":"9","doi-asserted-by":"crossref","first-page":"771","DOI":"10.2353\/jmoldx.2010.090169","article-title":"A diagnostic assay based on microRNA expression accurately identifies malignant pleural mesothelioma","volume":"12","author":"Aharonov","year":"2010","journal-title":"J Mol Diagn"},{"key":"10","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1002\/ijc.25285","article-title":"Downregulated microRNAs in the differential diagnosis of malignant pleural mesothelioma","volume":"127","author":"Marsit","year":"2010","journal-title":"Int J Cancer"},{"key":"11","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1165\/rcmb.2009-0060OC","article-title":"MicroRNA signature of malignant mesothelioma with potential diagnostic and prognostic implications","volume":"42","author":"Gaudino","year":"2010","journal-title":"Am J Respir Cell Mol Biol"},{"key":"12","article-title":"MiR-Score: A novel 6-microRNA signature that predicts survival outcomes in patients with malignant pleural mesothelioma","author":"Reid","year":"2014","journal-title":"Molecular Oncology"},{"key":"13","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1158\/0008-5472.CAN-09-3993","article-title":"hsa-miR-29c* is linked to the prognosis of malignant pleural mesothelioma","volume":"70","author":"Aharonov","year":"2010","journal-title":"Cancer research"},{"key":"14","first-page":"23","article-title":"Preclinical evaluation of microRNA-34b\/c delivery for malignant pleural mesothelioma","volume":"68","author":"Miyoshi","year":"2014","journal-title":"Acta medica Okayama"},{"key":"15","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/bjc.2013.731","article-title":"An RNAi-based screen reveals PLK1, CDK1 and NDC80 as potential therapeutic targets in malignant pleural mesothelioma","volume":"110","author":"Reid","year":"2014","journal-title":"British journal of cancer"},{"key":"16","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1097\/JTO.0b013e31820ce2c7","article-title":"Accuracy of diagnostic biopsy for the histological subtype of malignant pleural mesothelioma","volume":"6","author":"McCaughan","year":"2011","journal-title":"J Thorac Oncol"},{"key":"17","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1158\/1078-0432.CCR-11-2450","article-title":"Genome-wide miRNA expression profiling identifies miR-9-3 and miR-193a as targets for DNA methylation in non-small cell lung cancers","volume":"18","author":"Zochbauer-Muller","year":"2012","journal-title":"Clinical cancer research: an official journal of the American Association for Cancer Research"},{"key":"18","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1182\/blood-2012-07-444729","article-title":"Epigenetic silencing of microRNA-193a contributes to leukemogenesis in t(8, 21) acute myeloid leukemia by activating the PTEN\/PI3K signal pathway","volume":"121","author":"Nervi","year":"2013","journal-title":"Blood"},{"key":"19","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1158\/1535-7163.MCT-10-0061","article-title":"miR-12\/miR-215 influence 5-fluorouracil resistance through cell cycle-mediated mechanisms complementary to its post-transcriptional thymidilate synthase regulation","volume":"9","author":"Bandres","year":"2010","journal-title":"Molecular cancer therapeutics"},{"key":"20","doi-asserted-by":"crossref","first-page":"e1402","DOI":"10.1038\/cddis.2014.367","article-title":"The DNA methylation-regulated miR-193a-3p dictates the multi-chemoresistance of bladder cancer via repression of SRSF2\/PLAU\/HIC2 expression","volume":"5","author":"Zhu","year":"2014","journal-title":"Cell death & disease"},{"key":"21","doi-asserted-by":"crossref","first-page":"5639","DOI":"10.1074\/jbc.M111.291229","article-title":"DNA methylation-regulated miR-193a-3p dictates resistance of hepatocellular carcinoma to 5-fluorouracil via repression of SRSF2 expression","volume":"287","author":"Zhu","year":"2012","journal-title":"J Biol Chem"},{"key":"22","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/1476-4598-12-162","article-title":"Effects of miR-193a and sorafenib on hepatocellular carcinoma cells","volume":"12","author":"De Petro","year":"2013","journal-title":"Molecular cancer"},{"key":"23","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.ccr.2007.03.012","article-title":"Bacterially derived 400 nm particles for encapsulation and cancer cell targeting of chemotherapeutics","volume":"11","author":"Brahmbhatt","year":"2007","journal-title":"Cancer cell"},{"key":"24","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1007\/s10495-013-0841-7","article-title":"Ionizing radiation-inducible microRNA miR-193a-3p induces apoptosis by directly targeting Mcl-1","volume":"18","author":"Han","year":"2013","journal-title":"Apoptosis : an international journal on programmed cell death"},{"key":"25","doi-asserted-by":"crossref","first-page":"3446","DOI":"10.1158\/1078-0432.CCR-13-2797","article-title":"Effects of MAPK and PI3K pathways on PD-L1 expression in melanoma","volume":"20","author":"Ribas","year":"2014","journal-title":"Clinical cancer research : an official journal of the American Association for Cancer Research"},{"key":"26","first-page":"1766","article-title":"PTEN\/PI3K\/mTOR\/B7-H1 signaling pathway regulates cell progression and immuno-resistance in pancreatic cancer","volume":"60","author":"Tang","year":"2013","journal-title":"Hepato-gastroenterology"},{"key":"27","article-title":"MicroRNA-193a-3p and -5p suppress the metastasis of human non-small-cell lung cancer by downregulating the ERBB4\/PIK3R3\/mTOR\/S6K2 signaling pathway","author":"Yao","year":"2014","journal-title":"Oncogene"},{"key":"28","doi-asserted-by":"crossref","first-page":"560","DOI":"10.3892\/etm.2011.436","article-title":"microRNA-192, -194 and -215 are frequently downregulated in colorectal cancer","volume":"3","author":"Xu","year":"2012","journal-title":"Experimental and therapeutic medicine"},{"key":"29","doi-asserted-by":"crossref","first-page":"5332","DOI":"10.1038\/onc.2013.478","article-title":"MicroRNA-192 suppresses liver metastasis of colon cancer","volume":"33","author":"Wang","year":"2014","journal-title":"Oncogene"},{"key":"30","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.clcc.2011.06.002","article-title":"Prognostic significance of miR-215 in colon cancer","volume":"10","author":"Ju","year":"2011","journal-title":"Clinical colorectal cancer"},{"key":"31","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1093\/carcin\/bgs126","article-title":"miR-192, miR-194, miR-215, miR-200c and miR-141 are downregulated and their common target ACVR2B is strongly expressed in renal childhood neoplasms","volume":"33","author":"Guertl","year":"2012","journal-title":"Carcinogenesis"},{"key":"32","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1158\/0008-5472.CAN-07-5194","article-title":"Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer","volume":"68","author":"Inazawa","year":"2008","journal-title":"Cancer Res"},{"key":"33","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.1038\/onc.2011.62","article-title":"MicroRNA-193a represses c-kit expression and functions as a methylation-silenced tumor suppressor in acute myeloid leukemia","volume":"30","author":"Yu","year":"2011","journal-title":"Oncogene"},{"key":"34","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.cancergencyto.2010.03.014","article-title":"The role of microRNA in human lung squamous cell carcinoma","volume":"200","author":"Wang","year":"2010","journal-title":"Cancer genetics and cytogenetics"},{"key":"35","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1038\/jid.2010.63","article-title":"MicroRNA expression profiles associated with mutational status and survival in malignant melanoma","volume":"130","author":"Lui","year":"2010","journal-title":"The Journal of investigative dermatology"},{"key":"36","doi-asserted-by":"crossref","first-page":"e18232","DOI":"10.1371\/journal.pone.0018232","article-title":"Association of MiR-12 with soluble mesothelin-related peptides, a marker for malignant mesothelioma","volume":"6","author":"Tomasetti","year":"2011","journal-title":"PloS one"},{"key":"37","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/modpathol.2011.144","article-title":"Epithelial-mesenchymal transition in malignant mesothelioma","volume":"25","author":"Fassan","year":"2012","journal-title":"Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc"},{"key":"38","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1159\/000356605","article-title":"Demethylation of miR-9-3 and miR-193a genes suppresses proliferation and promotes apoptosis in non-small cell lung cancer cell lines","volume":"32","author":"Hu","year":"2013","journal-title":"Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology"},{"key":"39","doi-asserted-by":"crossref","first-page":"4965","DOI":"10.1158\/1078-0432.CCR-10-3040","article-title":"Epigenetic silencing of microRNA-34b\/c plays an important role in the pathogenesis of malignant pleural mesothelioma","volume":"17","author":"Miyoshi","year":"2011","journal-title":"Clinical cancer research : an official journal of the American Association for Cancer Research"},{"key":"40","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nature12080","article-title":"EGFR modulates microRNA maturation in response to hypoxia through phosphorylation of AGO2","volume":"497","author":"Liu","year":"2013","journal-title":"Nature"},{"key":"41","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.lungcan.2005.07.010","article-title":"Expression and prognostic significance of hypoxia-inducible factor 1alpha (HIF-1alpha) in malignant pleural mesothelioma (MPM)","volume":"51","author":"Fennell","year":"2006","journal-title":"Lung cancer"},{"key":"42","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.lungcan.2006.08.012","article-title":"EGFR expression: associations with outcome and clinicopathological variables in malignant pleural mesothelioma","volume":"54","author":"O'Byrne","year":"2006","journal-title":"Lung cancer"},{"key":"43","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.lungcan.2005.10.016","article-title":"EGFR overexpression in malignant pleural mesothelioma. An immunohistochemical and molecular study with clinico-pathological correlations","volume":"51","author":"Roncalli","year":"2006","journal-title":"Lung cancer"},{"key":"44","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1083\/jcb.201110008","article-title":"BRCA1 regulates microRNA biogenesis via the DROSHA microprocessor complex","volume":"197","author":"Amano","year":"2012","journal-title":"The Journal of cell biology"},{"key":"45","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/path.3979","article-title":"BRCA1 is an essential mediator of vinorelbine-induced apoptosis in mesothelioma","volume":"227","author":"Fennell","year":"2012","journal-title":"The Journal of pathology"},{"key":"46","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1172\/JCI43897","article-title":"A microRNA-dependent program controls p53-independent survival and chemosensitivity in human and murine squamous cell carcinoma","volume":"121","author":"Ellisen","year":"2011","journal-title":"The Journal of clinical investigation"},{"key":"47","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.3892\/ijo.2013.1896","article-title":"Gain-of-function microRNA screens identify miR-193a regulating proliferation and apoptosis in epithelial ovarian cancer cells","volume":"42","author":"Yoshida","year":"2013","journal-title":"International journal of oncology"},{"key":"48","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1158\/1535-7163.MCT-10-0427","article-title":"A microRNA screen to identify modulators of sensitivity to BCL2 inhibitor ABT-263 (navitoclax)","volume":"9","author":"Semizarov","year":"2010","journal-title":"Molecular cancer therapeutics"},{"key":"49","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1007\/s00018-014-1584-5","article-title":"Role of microRNAs in malignant mesothelioma","volume":"71","author":"Grossi","year":"2014","journal-title":"Cell Mol Life Sci"},{"key":"50","first-page":"00012","article-title":"MicroRNA Therapeutics - Back in Vogue?","volume":"2","author":"Reid","year":"2015","journal-title":"J Investig Genomics"},{"key":"51","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.lungcan.2010.01.002","article-title":"Tissue and serum EGFR as prognostic factors in malignant pleural mesothelioma","volume":"70","author":"Mokhtar","year":"2010","journal-title":"Lung cancer"},{"key":"52","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1007\/s00432-008-0384-4","article-title":"Epidermal growth factor receptor gene mutation, amplification and protein expression in malignant pleural mesothelioma","volume":"134","author":"Fujii","year":"2008","journal-title":"J Cancer Res Clin Oncol"},{"key":"53","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1002\/jso.21901","article-title":"Epidermal growth factor receptor overexpression in malignant pleural mesothelioma: prognostic correlations","volume":"104","author":"Casadio","year":"2011","journal-title":"J Surg Oncol"},{"key":"54","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1158\/0008-5472.CAN-14-0337","article-title":"Discovery of mesothelin and exploiting it as a target for immunotherapy","volume":"74","author":"Hassan","year":"2014","journal-title":"Cancer Res"},{"key":"55","article-title":"Loss of mir-223 and JNK Signalling Contribute to Elevated Stathmin in Malignant Pleural Mesothelioma","author":"Badrian","year":"2015","journal-title":"Mol Cancer Res"},{"key":"56","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3389\/fgene.2012.00120","article-title":"miR-34 - a microRNA replacement therapy is headed to the clinic","volume":"3","author":"Bader","year":"2012","journal-title":"Frontiers in genetics"},{"key":"57","first-page":"ii16","article-title":"MesomiR 1: A Phase I study of TargomiRs in patients with refractory malignant pleural mesothelioma (MPM) and lung cancer (NSCLC)","volume":"26","author":"Reid","year":"2015","journal-title":"Annals of oncology: official journal of the European Society for Medical Oncology \/ ESMO"},{"key":"58","first-page":"128","article-title":"Validation of tissue microarray technology in malignant pleural mesothelioma","volume":"43","author":"Klebe","year":"2011","journal-title":"Pathology"},{"key":"59","doi-asserted-by":"crossref","first-page":"e58132","DOI":"10.1371\/journal.pone.0058132","article-title":"Phenotypes and karyotypes of human malignant mesothelioma cell lines","volume":"8","author":"Bowman","year":"2013","journal-title":"PloS one"},{"key":"60","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1158\/1535-7163.MCT-13-0065","article-title":"Synergistic anticancer activity of arsenic trioxide with erlotinib is based on inhibition of EGFR-mediated DNA double-strand break repair","volume":"12","author":"Heffeter","year":"2013","journal-title":"Molecular cancer therapeutics"},{"key":"61","first-page":"1955","article-title":"Copper- and zinc-containing superoxide dismutase, manganese-containing superoxide dismutase, catalase, and glutathione peroxidase in normal and neoplastic human cell lines and normal human tissues","volume":"42","author":"Roos","year":"1982","journal-title":"Cancer Res"},{"key":"62","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/ijc.2910510220","article-title":"Hematopoietic growth factors secreted by seven human pleural mesothelioma cell lines: interleukin-6 production as a common feature","volume":"51","author":"Stahel","year":"1992","journal-title":"Int J Cancer"},{"key":"63","first-page":"321","article-title":"Potent subunit-specific effects on cell growth and drug sensitivity from optimised siRNA-mediated silencing of ribonucleotide reductase","volume":"5","author":"Watson","year":"2009","journal-title":"Journal of RNAi and gene silencing : an international journal of RNA and gene targeting research"},{"key":"64","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1097\/JTO.0b013e3182a0840a","article-title":"ZIC1 is silenced and has tumor suppressor function in malignant pleural mesothelioma","volume":"8","author":"Reid","year":"2013","journal-title":"Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer"},{"key":"65","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1097\/JTO.0b013e3182572e83","article-title":"Increased circulating miR-625-3p: a potential biomarker for patients with malignant pleural mesothelioma","volume":"7","author":"Reid","year":"2012","journal-title":"Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer"},{"key":"66","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH Image to ImageJ: 25 years of image analysis","volume":"9","author":"Eliceiri","year":"2012","journal-title":"Nat Methods"},{"key":"67","volume-title":"AJCC Cancer Staging Manual","author":"Trotti","year":"2010"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.4346","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,15]],"date-time":"2020-07-15T15:26:56Z","timestamp":1594826816000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.4346"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,22]]},"references-count":67,"journal-issue":{"issue":"27","published-print":{"date-parts":[[2015,9,15]]}},"alternative-id":["4346","26125439"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.4346","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,22]]}}}